chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a grandmother concerning her 4.5 year old granddaughter with no reported allergies or medical history who on approximately 26-NOV-2007, "three weeks ago," was vaccinated IM in the leg with a 0.5 mL dose of PedvaxHIB. Concomitant therapy included vaccination with a dose of influenza virus vaccine (unspecified) in the opposite leg. On approximately 26-NOV-2007, the same day as the vaccination, the patient's leg that was vaccinated with PedvaxHIB "became all red and hard as a rock" for two weeks. The patient sought unspecified medical attention. On approximately 17-DEC-2007, "just this week," the patient developed an "uncontrollable fever and blisters inside her mouth." The patient was brought to the emergency room and was treated with unspecified antibiotics and pain medication. The patient was not admitted to the hospital. At the time of this report, the patient was recovering. Additional information has been requested.
right sided back pain--severe. MRI done 2 weeks after onset showed signficant lumbar spondylosis and chronic disk changes. patient wished that we report this because of the temporal relationship between vaccine and pain onset.
Cold; Felt feverish; Chills; This spontaneous case was reported by a patient and describes the occurrence of NASOPHARYNGITIS (Cold), PYREXIA (Felt feverish) and CHILLS (Chills) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Concurrent medical conditions included Drug allergy (Allergic to aspirin).  On 10-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Cold), PYREXIA (Felt feverish) and CHILLS (Chills). At the time of the report, NASOPHARYNGITIS (Cold), PYREXIA (Felt feverish) and CHILLS (Chills) had resolved.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2023-708449 (Patient Link).
26 y/o female dental hygienist presented to the HC on 11/1/2006 for evaluation of left shoulder inflammatory lump, swelling, redness, and pain.  The patient had received Tdap vaccination into the left shoulder and inactivated influenza into the right shoulder on 10/30/2006 at Hospital as part of the hospital's recent immunization drive. The symptoms in the left shoulder started within 5-6 hours after Tdap vaccine receipt. No other systemic or allergic symptoms reported.
Pt rec'd MENVEO in office on 6-26-17 local RXN with swelling and LG fvr started on 6-28-17 called office was told to do cold compresses and mark area of RXN, to call back if worse, apt was made on 6-29-17-Pt started on KEFLEX for cellulitis.
Patient woke up with forehead and back of hand rash; she had swelling in the morning after being vaccinated; This is a spontaneous report from a contactable pharmacist. A 29-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: unknown, via an unspecified route of administration on 21Dec2020 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient woke up with forehead and back of hand rash and she had swelling in the morning after being vaccinated. She took a BENADRYL and went to the ED (Emergency Department). Event onset date was on 22Dec2020. The event was reported as non-serious. The outcome of forehead and back of hand rash and she had swelling was unknown.  Information on Lot/Batch number has been requested.
Numbness; Tingling from shoulder down to hand; Wrist pains; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 24Apr2021 at 12:15 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history included gastroesophageal reflux disease (GERD), generalized anxiety disorder, carpal tunnel and sulfonamide allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Concomitant medications included fluoxetine hydrochloride (POZAC), methylphenidate hydrochloride (CONCERTA), atomoxetine hydrochloride (STRATTERA), glycopyrronium tosylate (QBREXZA) and Rethinylestradiol, norgestimate (MILI) from an unknown date for an unknown indication and unknown if ongoing. On 24Apr2021 at 13:15, after about 35-45 minutes, the patient experienced numbness and tingling from shoulder down to hand accompanied by wrist pains. She was unsure if that is a common side effect, but it was not listed so she wanted to report it anyways. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events numbness, tingling from shoulder down to hand and wrist pain were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Approximately 4 hours after immunizations, child developed swollen, reddened, warm to touch area. Extends from base of deltoid to just above left elbow. Child complains of discomfort and itching at home. Had IPV and DTaP in that arm. Able to flex elbow joint, leaving reddened creases on lower arm. No complaints of finger or arm numbness. Recommended Motrin every 4-6 hours PRN Pain. Recommended Benadryl Elixir every 4-6 hours for itching.
Felt the flu shot was given really high in my shoulder. After, experienced more pain than usual, pain increased each day and I experienced limited mobility and increased weakness. On day 4 went to doctor and started ibuprofen for inflammation. Pain still got worse after that. Hard to even put a shirt on. On day 10, went back to the doctor and they got an MRI later in the day. MRI showed inflammation and fluid build-up so started on a steroid. Shoulder still is hurting even on the steroids and having some weakness and limited mobility. Now waiting to see if the pain goes away when steroid is done. Doctor suggested it may be painful/inflamed due to the shot being given too high and going through the muscle and into the bursa sac. Pain is most severe when shoulder is reached above the head or moved laterally behind or across body.
This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received PREVNAR 13, on an unknown date in 2016 at 0.5 ml single for immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2016 the patient experienced joint pain, muscle pain and she couldn't move neck left or right. She stated that the muscle around her neck was bad and she couldn't turn it left or right. She went to the hospital and got a shot for a muscle relaxant. She was not admitted to the hospital, she was treated in the emergency room. The outcome of the events was unknown.
Macular papular rash-generalized x2 days. Today x4 vesicles (x2back; x1 chest; x1 right neck, Left elbow/lower forearm)
Localized vaccine reaction on the left leg. Redness and swelling in the area about 3-4 inches wide.
Every time I am ill, it comes as a bad cough. This cough was a very severe cough. I treated with cold medicine and used VICKS on my chest, CORICIDIN and ROBITUSSIN. On the 27th of June, 2022, I took a home COVID-19 and it was positive. I called my physician and I started on medications they suggested, TESSLON PEARLS and MEDROL DOSE steroid pack. I asked if I should use nebulizer medicine and the physician's assistant sent that. Immediately the cough started to ease up.
3 weeks of diarrhea which lead to dehydration which lead to IVs. After 2 weeks of diarrhea On Dec 6th I called my doctor because I had been sick for 2 weeks and he sent me to the ER. I was at the ER then hospitalized until Dec 9th. I still have services -nurse, physical therapist, aide - coming to the house. Diarrhea started on the 23rd of November. I'm still unsteady on my feet.
On the 8th day after the 1st vaccine I started throwing up that evening and developed an anxiety and loss of appetite.  I did not suspect the vaccine because it was 8 days later.  After I got  my 2nd vaccine everything repeated again on the 8th day following the 2nd shot and again started throwing up but this time the anxiety developed into a panic attacks and a complete loss of appetite.  My blood pressure and pulse was elevated and keep going up and down through out the day.  I made an appointment with the doctor the next day because I felt something was wrong and off.  The blood test came back normal.  Today is day 32 day post 2nd vaccine and my anxiety and panic attacks have not yet disappeared.  I am still dealing with the loss of appetite and lost 13 lbs since the vaccine.   My blood pressure and pulse still goes up and down through out the day.  Prior to the vaccine I was a completely normal and healthy person and have never had an anxiety or panic attacks before.
Peripheral neuropathy, no treatment,  continuous tingling in feet with occasional painful flare-ups, continuing so far since July 2022
This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 on 30-Jan-2021 and Dose 2 on 08-Mar-2021 (Outside window period)) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Vomiting.On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 on 30-Jan-2021 and Dose 2 on 08-Mar-2021 (Outside window period)). On 08-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 on 30-Jan-2021 and Dose 2 on 08-Mar-2021 (Outside window period)) had resolved. No concomitant medication was provided. No treatment medication was provided. This case was linked to MOD-2021-034395, MOD-2021-385693 (Patient Link).
This spontaneous report was received from a healthcare worker regarding unspecified number of patients of unknown age and gender. There was no information on patients pertinent medical history and drug reactions or allergies. The healthcare worker reported that on an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL (product lot#, expiry date not reported). No adverse effects were reported. There was no product quality complaint involved. The outcome of the events was unknown. This is one of the several reports from the same source. Additional information has been requested.
She had her first COVID-19 vaccine on 30 Aug 2021.  She became sick on 6 Sept 2021 and was diagnosed with COVID-19 on 8 Sept 2021.  She had an uneventful time in isolation but developed shortness of breath and chest pressure when moving out of her isolation room on 19 Sept 2021.  She continued to have these symptoms on exertion as well as palpitations.  Her EKG showed T wave changes.  She had a normal ESR, CRP, and Trop T.  She had an essentially negative echocardiogram.  She saw cardiology who suspected possible myocarditis.  She had a normal cardiac MRI in December.  Her symptoms gradually resolved aside from persistent tachycardia for which she was started on a beta blocker.  She has been weaning off this.  Cardiology made a presumptive diagnosis of myocarditis that by November appeared to have resolved.  I discussed the case and it recommended that she not received a second mRNA vaccine as it appears she had myocarditis and we have no way of knowing if it was from the vaccine or from her COVID infection, although myocarditis is more commonly associated with a COVID infection.
8/3/2021- patient to ED with SOB, nausea,vomit and abd cramping, diarrhea. Held in ED and admitted on 8/4/2021
Woke up next day with shortness of breath along with regular vaccine side effects. Progressed to headaches the next week, then vertigo, then a  COVID-negative cough/cold a week later, then neurological long-COVID symptoms (numbness and tingling in one leg, unilateral weakness, buzzing, muscle fatigue and post-exertional malaise, vision changes, heart palpitations, mental health problems etc.). Ongoing for 7 months with little improvement.
Sore arm; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no conmed medication was included.  no treatment was mentioned.   This case was linked to US-MODERNATX, INC.-MOD-2021-052287 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-052287:crosslink - second dose
Right sided temple headache since first day. After 5 weeks headache has not gone away. Inflammation levels are double the normal amount. Had aura 3 times as well.
Narrative: COVID infection following COVID vaccine series 03/30, MODERNA, dose #1 04/27, MODERNA, dose #2 08/16 t cc: chills, fatigue, headache, rhinorrhea, sore throat exposure: unknown 08/19 COVID swab, result: detected 08/19 SARS-COV-2 Variant Sequencing result: pending 08/25 COVID swab, result: detected clinically resolved
This spontaneous report was received from a physician via a company representative, referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 05-APR-2016, the patient was vaccinated with an improperly stored dose of VAQTA "25U/0.5ml - SD LLok wCap Ped" which had a lot number of L02259 and expiration date on 06-APR-2017 (route of administration and anatomical location were not reported). There were no concomitant medications provided. No adverse effects reported. No product quality complaint was involved. On an unspecified date, the VAQTA vaccine had two temperature excursions; one of 96 hours and other one of 360 hours. The lowest recorded temperature was 33 F (0.555555556 Celsius) and the highest recorded temperature was not mentioned. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". This is one of several cases from the same reporter. Additional information has been requested.
it was rpt fr person in MD ofc concerning pt who was vax & subsequently pt exp measles w/small bumps all over lasting 2-3 days.
herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 71-year-old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 17-JUN-2011, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route of administration not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced herpes zoster and was treated by a physician. The outcome of herpes zoster was unknown. The reporter considered herpes zoster to be related to Zoster Vaccine Live ( ZOSTAVAX).   Additional information has been requested.
This spontaneous report as received from a nurse practitioner refers to a 5 week old male patient with vaccination. On 21-FEB-2014 the patient was vaccinated with VAQTA (lot # J005081, Expiry date 22-OCT-2015) 0.5 ml in the right anterior thigh instead of hepatitis B vaccine. No concomitant medications were reported. No adverse events were reported. No product quality issue was reported. Additional information has been requested.
Moderate flu-like symptoms for 24 hours -- sore muscles, joint pain, headache, fatigue, nausea, constipation, loss of appetite. Severe enough that I took afternoon off from work.
epistaxis one day after and two days after.  Also with one episode of rectal bleeding the day after.  CBC, PT and PTT were all normal.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 37-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 37 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 1 D" (unspecified if ongoing), notes: Type 1 D. Concomitant medication(s) included: STATIN [NYSTATIN], stop date: 11Dec2022. Past drug history included: Ceclore, reaction(s): "Known allergies: ceclore"; Penicillin, reaction(s): "Known allergies: Penicillin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Other medications in two weeks. Paxlovid started on 11Dec2022 for Treatment of COVID-19.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported drug ineffective / COVID-19 cannot be ruled out
vaccine was administered outside the administration guideliness; This spontaneous report was received from a medical assistant referring to a 15 year old patient, of unknown gender.  No other information was provided regarding the patient's medical history or drug reactions/allergies.  Concomitant therapies included sterile diluent (STERILE DILUENT).      On an unspecified date, the patient was vaccinated with one dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) for prophylaxis, outside the administration guidelines according to the prescribing information.  At the time of the report, the patient's outcome was unknown.
The first 24 hours Started with fever and chills that lasted for three hours. Then fatigue. The next 24 hours, no fever but stomach cramps and severe diarrhea. Still fatigue and muscle soreness.
Pt became light headed and dizzy the next morning upon rising. Pt went to ER with daughter that experienced same SE and were checked out and all other issues were ruled out. Pt was told it most likely related to vaccinations.
Please contact the clinic RN for the exact vaccine info including lot number.  He received both vaccines on November 3rd and complained of headache, chest pain, dyspnea and vision changes the following day.  His vitals were within normal limits.  He was given nitroglycerin and sent to the local ED.  Work up including troponins and EKG were normal but he was given a prescription for nitroglycerin based upon his complaint of intermittent chest pains prior to the event.  Upon return to prison, he was back to his baseline.
Approximately 30 minutes after receiving the vaccination, the patient returned to the pharmacy and stated her upper lip felt tingly and larger than normal and she was having generalized itchy feelings around her face.  We gave her diphenhydramine 25 mg and observed her for an additional 20 minutes.  At that time, she stated she felt fine and left the pharmacy area.
Pt recvd 1st dose of Hep B vax on 10APR91 & on 12MAY91 pt devel pain in knee & over the next 5 days, it spread to ankles, wrists, neck & shoulders; By 17MAY91 th pt recovered;
Throat and tongue swelling. I was treated in the ER for allergic reaction.  Received IV benadryl, solumedrol and Tagamet.  Released after 2 and one half hours. 10/14/09 ED records received service date 10/12/09. Assessment: Allergic reaction to FluMist. Patient complained of throat swelling. Later said he felt better and was discharged.  10/20/2009 PCP records for wellness visit 10/20/2009   L
Patient admitted 12/12/2021 with concern for bacterial pneumonia after presenting with right-sided chest pain, as well as left leg cellulitis. The patient was started on IV azithromycin and ceftriaxone, subsequently switched to IV doxycycline and ceftriaxone.  She was found to have MRSA bacteremia, and IV vancomycin was initiated. She will be discharged on IV vancomycin. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Started with itching an a couple red bumps at injection site that gradually increased over the next few days, starting on 1/10/21.  Today, 1/12/21 there are raised red bumps and itching roughly about an inch wide and two inches long.
Site of injection developed multiple erythematous papules, itchy, hive-like, a few hours after vaccine was given.  Reaction was local, no systemic reaction.
Clammy on his back; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 82-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot number: EL183), via intramuscular route in left arm, on 09Feb2021 at 02:10 (82-year-old at the time of vaccination), as dose 1, single for covid-19 immunisation. Medical history included has a pacemaker and diabetes from an unknown date and unknown if ongoing. The patient has allergy to iodine. The concomitant medications were reported as none. The patient had not received any vaccine within four weeks. The patient had no covid prior to vaccination. The patient was not tested since vaccination. On 09Feb2021 at 06:30 am, the patient experienced clammy on his back. No relevant tests was conducted. No treatment was received for the events. The event reported as non-serious. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported), via intramuscular in Right upper arm, on 02Mar2021 at 10:15 (82-year-old at the time of vaccination), as dose 2, single for covid-19 immunisation. The outcome of the event was recovered an unspecified date on 2021.  It was reported as the Pfizer product had a causal effect to the adverse event was yes  Follow up attempts are completed. No further information is expected.
About 1.5 hours after the injection, I developed redness and itchiness in my left arm. It started at the site of the injection and slowly traveled down to my wrist. At 2 pm, I took 50 mg Benadryl and iced the arm and the redness and itchiness subsided. It returned at 9 pm. I then took another dose of 50 mg Benadryl.  Symptoms subsided. On the following morning, there was still a little itchiness, but no redness or swelling.
Patient was given ADACEL vaccine at 2:38 pm. He became/develops redness, sweat, hot SOB. He started have tightening in his chest/neck. He almost lost consciousness. Gave the EPIPEN and patient became more alert after about a min. Ambulance came and took him away.